No valuation for Chance Pharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($52.1M) and the funding record below are the closest available signals.
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Chance Pharmaceuticals
- ·The full record, as it builds
Funding history
No funding rounds for Chance Pharmaceuticals are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Chance Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Chance Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Chance Pharmaceuticals raised?
- Chance Pharmaceuticals has raised $52.1M in total funding across its recorded rounds.